CTRI/2021/05/033907招募中未知
INdian Real world EvidenCe Of Rivaroxaban use in coronary artery Disease ââ?¬â?? A prospective observational cohort study. - IN-RECORD
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Age >18 years, either gender having a diagnosis of coronary artery disease and meeting the following additional criteria
- •a. Taking antiplatelet therapy for coronary artery disease or peripheral artery disease
- •b. Having ââ?°Â¥2 vascular beds affected or eligible to take an oral anticoagulant therapy
- •2. Willing to provide written informed consent and for follow up of one year from the date of registration.
排除标准
- •1. Patients having a diagnosis of atrial fibrillation (valvular or non-valvular) prior to or at the time of index acute coronary event or diagnosis.
- •2. Patients on high doses of newer oral anticoagulants - ââ?°Â¥10mg per day.
- •3. Patients on vitamin K antagonist for any reason.
- •4. Patients not likely to cooperate for data collection and follow up ââ?¬â?? investigatorââ?¬•s decision.
研究者
相似试验
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
尚未招募
Unknown
To study the side effects and effectiveness effects of Tablet Ribociclib in hormone positive , HER2 negative breast cancer patientsCTRI/2024/01/061744ot applicable
已完成
不适用
Prospective Registry of rivaroxaban management of cancer-associated venous thromboembolism studyCancer-associated venous ThromboembolismJPRN-UMIN000034933International University of Health and Welfare500
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsVenous thromboembolism (VTE)MedDRA version: 19.0 Level: LLT Classification code 10066899 Term: Venous thromboembolism System Organ Class: 100000004866EUCTR2015-001630-21-GBJanssen-Cilag International N.V.841